//
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
A population-based study of 92 clinically recognised risk factors for heart failure: co-occurrence, prognosis and preventive potential